Literature DB >> 27277635

Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography.

Rina Tamai1, Tomoya Hara1, Hirotsugu Yamada2,3, Susumu Nishio4, Mika Bando1, Junko Hotchi1, Shuji Hayashi4, Toshiyuki Niki1, Tetsuya Kitagawa5, Masataka Sata1,4.   

Abstract

An 83-year-old woman presented to our echocardiographic center with symptoms of right heart failure. A dual-chamber DDDR pacemaker had been implanted 9 years earlier. Two-dimensional echocardiography revealed right atrial and ventricular enlargement and massive tricuspid regurgitation with immobilization of the anterior leaflet of the tricuspid valve. Three-dimensional transesophageal echocardiography showed that the pacemaker lead had punctured the leaflet. These echocardiographic findings were confirmed during surgery. The pacemaker lead was transected and removed, and pericardial patch closure of the leaflet hole and tricuspid annuloplasty were performed. The mechanism of regurgitation was elucidated by real-time three-dimensional echocardiography, and surgical repair was straightforward.

Entities:  

Keywords:  3-Dimensional echocardiography; Pacemaker-lead puncture; Tricuspid regurgitation

Year:  2013        PMID: 27277635     DOI: 10.1007/s10396-013-0459-y

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  2 in total

1.  Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.

Authors:  Grace Lin; Rick A Nishimura; Heidi M Connolly; Joseph A Dearani; Thoralf M Sundt; David L Hayes
Journal:  J Am Coll Cardiol       Date:  2005-05-17       Impact factor: 24.094

2.  Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads.

Authors:  Yoshihiro Seo; Tomoko Ishizu; Hideki Nakajima; Yukio Sekiguchi; Shigeyuki Watanabe; Kazutaka Aonuma
Journal:  Circ J       Date:  2008-09       Impact factor: 2.993

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.